Structure Therapeutics (GPCR) Accumulated Depreciation & Amortization (2022 - 2025)
Quarterly Accumulated Depreciation & Amortization rose 81.48% to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, up 81.48% year-over-year, with the annual reading at $3.0 million for FY2025, 81.48% up from the prior year.
Structure Therapeutics' Accumulated Depreciation & Amortization history spans 4 years, with the latest figure at $3.0 million for Q4 2025.
- Accumulated Depreciation & Amortization came in at $3.0 million for Q4 2025, up from $1.6 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $3.0 million in Q4 2025 to a low of $349000.0 in Q4 2022.
- The 4-year median for Accumulated Depreciation & Amortization is $755000.0 (2023), against an average of $1.0 million.
- Year-over-year, Accumulated Depreciation & Amortization soared 154.04% in 2024 and then skyrocketed 81.48% in 2025.
- Structure Therapeutics' Accumulated Depreciation & Amortization stood at $349000.0 in 2022, then skyrocketed by 84.53% to $644000.0 in 2023, then soared by 154.04% to $1.6 million in 2024, then surged by 81.48% to $3.0 million in 2025.
- Per Business Quant, the three most recent readings for GPCR's Accumulated Depreciation & Amortization are $3.0 million (Q4 2025), $1.6 million (Q4 2024), and $1.4 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.97 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 866,000.00 |
| Mar 31, 2024 | 866,000.00 |
| Dec 31, 2023 | 644,000.00 |
| Dec 31, 2023 | 644,000.00 |
| Sep 30, 2023 | 572,000.00 |
| Sep 30, 2023 | 572,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Mar 31, 2023 | 419,000.00 |
| Mar 31, 2023 | 419,000.00 |
| Dec 31, 2022 | 349,000.00 |
| Dec 31, 2022 | 349,000.00 |